Ricardi to lead Micro Imaging's commercialisation
This article was originally published in Clinica
Micro Imaging Technology (MIT) has promoted John Ricardi to the newly-created role of executive vice-president. Mr Ricardi will become MIT's primary spokesperson and lead the commercialisation of the company's microbe identification technology. He will assume his new role, in addition to the responsibilities of his previous role as chief operating officer. San Clemente, California-based MIT has developed a rapid microbial ID system for identifying the presence of bacteria – the system has numerous applications, including clinical diagnostics.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.